Showing 1 - 9 results of 9 for search 'A. D. Durnev', query time: 0.02s Refine Results
  1. 1
    Preclinical safety studies of medicines in the Eurasian economic union

    Preclinical safety studies of medicines in the Eurasian economic union by G. N. Engalycheva, R. D. Syubaev, A. D. Durnev

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part II: Biochemical and Pathomorphological Studies)

    Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part II: Biochemical and Pathomorphological Studies) by A. V. Sorokina, S. V. Alekseeva, N. V. Eremina, A. D. Durnev

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Evaluation of allergenic properties and immunotoxicity of dipeptide mimetic of brain-derived neurotrophic factor GSB-106

    Evaluation of allergenic properties and immunotoxicity of dipeptide mimetic of brain-derived neurotrophic factor GSB-106 by L. P. Kovalenko, K. V. Korzhova, R. V. Zhurikov, C. B. Nikitin, A. D. Durnev

    Published 2020-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Dna damage in myocardial cells of rats with experimental alcoholic cardiomyopathy: modifyng effects of fabomotizole and trimetazidene

    Dna damage in myocardial cells of rats with experimental alcoholic cardiomyopathy: modifyng effects of fabomotizole and trimetazidene by A. K. Zhanataev, I. A. Miroshkina, I. B. Tsorin, Z. V. Chayka, S. A. Kryzhanovskii, A. D. Durnev

    Published 2018-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Comparative study of the pharmacokinetics and biodistribution of various topical formulations of carbazole derivative CBL0100 in guinea pigs

    Comparative study of the pharmacokinetics and biodistribution of various topical formulations of carbazole derivative CBL0100 in guinea pigs by N. V. Eremina, V. I. Kazey, O. Y. Kravtsova, E. I. Skrabelinskaya, A. V. Purmal, A. D. Durnev

    Published 2020-04-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    On the mechanism of the antiarrhythmic action of fabomotizole hydrochloride in alcoholic cardiomyopathy

    On the mechanism of the antiarrhythmic action of fabomotizole hydrochloride in alcoholic cardiomyopathy by I. A. Miroshkina, L. M. Kozhevnikova, I. B. Tsorin, V. N. Stolyaruk, M. B. Vititnova, S. A. Kryzhanovskii, A. D. Durnev

    Published 2021-09-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    DNA Damages and White Blood Cell Death Processes in Victims with Severe Injury

    DNA Damages and White Blood Cell Death Processes in Victims with Severe Injury by V. V. Moroz, E. A. Myagkova, A. K. Zhanataev, G. A. Ryabov, D. A. Ostapchenko, A. D. Durnev, V. I. Reshetnyak

    Published 2014-08-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    GK-2 new drug with neuroprotective properties the study of acute and chronic toxicity of the finished dosage forms

    GK-2 new drug with neuroprotective properties the study of acute and chronic toxicity of the finished dosage forms by A. V. Sorokina, S. V. Alekseeva, I. A. Miroshkina, A. V. Volkova, V. V. Zabrodina, K. S. Kachalov, I. V. Alekseev, A. D. Zaharov, P. Yu. Povarnina, A. D. Durnev

    Published 2019-02-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    The study of the acute and chronic toxicity dipeptide mimetic of brain-derived neurotrophic factor GSB-106 finished dosage form

    The study of the acute and chronic toxicity dipeptide mimetic of brain-derived neurotrophic factor GSB-106 finished dosage form by S. V. Alekseeva, A. V. Sorokina, A. V. Volkova, V. V. Zabrodina, I. A. Miroshkina, K. S. Kachalov, I. V. Alekseev, A. D. Zaharov, P. Yu. Povarnina, A. D. Durnev

    Published 2019-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: